New Zealand Medical Device Registration & Certification
Important Notes
- Medsafe Regulation & WAND Database: All medical devices (including IVDs) are regulated by Medsafe. Approved devices are listed in the Web Assisted Notification of Devices (WAND) database.
- Risk-Based Classification & Pathway: Medical devices follow GHTF/IMDRF risk classification rules (Class I-IV), determining the conformity assessment procedure (self-declaration, audit assessment, or Medsafe conformity assessment).
- Sponsor (Authorized Representative) Requirement: Foreign manufacturers must appoint a "Sponsor" located in New Zealand or Australia as the regulatory contact with Medsafe and assume product responsibility.
- Labeling & Instructions Requirements: All information must be in English. Labels must comply with the Medicines and Medical Devices Labeling Guide, including sponsor details, NZ Unique Device Identifier (if applicable), and key safety information.
- Joint Scheme with Australia (TTMA): Under the Trans-Tasman Mutual Recognition Agreement, some medical devices complying with Australian TGA requirements can access the NZ market via a streamlined process, and vice versa.
- Post-Market Surveillance Obligations: Sponsors must establish comprehensive post-market surveillance systems, report adverse events to Medsafe, and comply with periodic reporting requirements.
New Zealand Specific Requirements
- Small but Sophisticated High-Standard Market: The market is limited in size but maintains high regulatory standards aligned with major international markets (especially Australia and the EU), with stringent and transparent processes for medical devices.
- Medsafe-Driven "Value-Based" Access Model: Medsafe emphasizes lifecycle risk management for medical devices, and public hospital procurement often factors in cost-effectiveness and clinical value when evaluating new devices.
- Close Synergy with the Australian Market: Through agreements like TTMA, NZ and Australia have deep regulatory alignment for devices, making Australian TGA approval the most efficient route to NZ market access.
- Openness to Digital Health & Telehealth: The government actively supports digital health solutions and telehealth services, with relatively clear and favorable regulatory pathways for related medical devices.
- Pragmatic & Lifecycle-Oriented Regulation: Medsafe emphasizes lifecycle risk management and post-market surveillance for medical devices, responding promptly to safety signals.
Medical Devices Registration
Regulatory Requirements
- WAND Database Listing (Web Assisted Notification of Devices)
- Classification Management by Risk Level (Class I, IIa, IIb, III)
- Declaration of Conformity
- Quality Management System Certificate (ISO 13485)
- English Labeling and Instructions for Use
- Technical Documentation File
- Clinical Evaluation Report (if applicable)
- New Zealand Authorized Representative Agreement
- Post-Market Surveillance Plan
Main Process
- Product Classification Determination
- Technical Documentation Preparation
- Conformity Assessment Completion
- New Zealand Representative Appointment
- WAND Database Listing
- Market Access Completion
Registration Timeline
4-12 months
Official Fees
NZD 1,500 - 25,000
Service Fees
$10,000 - $30,000
Regulatory System Overview
Medsafe
New Zealand Medicines and Medical Devices Safety Authority
Responsible for medical device regulation, WAND database management, market surveillance, and adverse event monitoring. Operates as the primary medical device regulatory authority under the New Zealand Ministry of Health.
Medsafe-RB
Medsafe Recognized Bodies
Recognized conformity assessment bodies for medical devices in New Zealand, responsible for reviewing declarations of conformity and supporting the WAND database listing process.
TGA
Therapeutic Goods Administration Australia
Under the Trans-Tasman Mutual Recognition Agreement (TTMA), medical devices approved by TGA can access the New Zealand market through a streamlined process, making Australian approval the most efficient route to NZ.
Medical Devices Registration Process
Product Classification Determination
Determine product risk classification according to New Zealand medical device regulations (Class I, IIa, IIb, III)
Technical Documentation Preparation
Prepare complete technical documentation including declaration of conformity, clinical evaluation, risk management files
New Zealand Authorized Representative
Appoint authorized representative in New Zealand responsible for WAND database registration and regulatory affairs
WAND Database Listing
Complete medical device listing through Web Assisted Notification of Devices system
Declaration of Conformity
Manufacturer signs declaration of conformity confirming product compliance with New Zealand regulations